Literature DB >> 21521420

Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.

Islam Gamaleddin1, Carrie Wertheim, Andy Z X Zhu, Kathleen M Coen, Kiran Vemuri, Alex Makryannis, Steven R Goldberg, Bernard Le Foll.   

Abstract

The cannabinoid system appears to play a critical facilitative role in mediating the reinforcing effects of nicotine and relapse to nicotine-seeking behaviour in abstinent subjects based on the actions of cannabinoid (CB) receptor antagonists. However, the effects of CB receptor stimulation on nicotine self-administration and reinstatement have not been systematically studied. Here, we studied the effects of WIN 55,212-2, a CB1/2 agonist, on intravenous nicotine self-administration under fixed-ratio (FR) and progressive-ratio (PR) schedules of reinforcement in rats. The effects of WIN 55,212-2 on responding for food under similar schedules were also studied. In addition, the effects of WIN 55,212-2 on nicotine- and cue-induced reinstatement of nicotine seeking were also studied, as well as the effects of WIN 55,212-2 on nicotine discrimination. WIN 55,212-2 decreased nicotine self-administration under the FR schedule. However, co-administration of WIN 55,212-2 with nicotine decreased responding for food, which suggests that this effect was non-selective. In contrast, WIN 55,212-2 increased both nicotine self-administration and responding for food under the PR schedule, produced dose-dependent reinstatement of nicotine seeking, and enhanced the reinstatement effects of nicotine-associated cues. Some of these effects were reversed by the CB1 antagonist rimonabant, but not by the CB2 antagonist AM630. In the drug discrimination tests between saline and 0.4 mg/kg nicotine, WIN 55,212-2 produced no nicotine-like discriminative effects but significantly potentiated discriminative stimulus effects of nicotine at the low dose through a CB1-receptor-dependent mechanism. These findings indicate that cannabinoid CB1-receptor stimulation increases the reinforcing effects of nicotine and precipitates relapse to nicotine-seeking behaviour in abstinent subjects. Thus, modulating CB1-receptor signalling might have therapeutic value for treating nicotine dependence.
© 2011 The Authors, Addiction Biology © 2011 Society for the Study of Addiction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21521420     DOI: 10.1111/j.1369-1600.2011.00314.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  45 in total

1.  Inhibition of monoacylglycerol lipase reduces nicotine reward in the conditioned place preference test in male mice.

Authors:  Pretal P Muldoon; Lois S Akinola; Joel E Schlosburg; Aron H Lichtman; Laura J Sim-Selley; Anu Mahadevan; Benjamin F Cravatt; M Imad Damaj
Journal:  Neuropharmacology       Date:  2020-05-30       Impact factor: 5.250

2.  Differential associations of combined vs. isolated cannabis and nicotine on brain resting state networks.

Authors:  Francesca M Filbey; Suril Gohel; Shikha Prashad; Bharat B Biswal
Journal:  Brain Struct Funct       Date:  2018-06-07       Impact factor: 3.270

3.  Fatty acid amide hydrolase (FAAH) inactivation confers enhanced sensitivity to nicotine-induced dopamine release in the mouse nucleus accumbens.

Authors:  Francisco J Pavon; Antonia Serrano; Nimish Sidhpura; Ilham Polis; David Stouffer; Fernando Rodriguez de Fonseca; Benjamin F Cravatt; Rémi Martin-Fardon; Loren H Parsons
Journal:  Addict Biol       Date:  2017-06-29       Impact factor: 4.280

Review 4.  Nicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research.

Authors:  Jack E Henningfield; Tracy T Smith; Bethea A Kleykamp; Reginald V Fant; Eric C Donny
Journal:  Psychopharmacology (Berl)       Date:  2016-10-21       Impact factor: 4.530

5.  Electrical stimulation of the insular region attenuates nicotine-taking and nicotine-seeking behaviors.

Authors:  Abhiram Pushparaj; Clement Hamani; Wilson Yu; Damian S Shin; Bin Kang; José N Nobrega; Bernard Le Foll
Journal:  Neuropsychopharmacology       Date:  2012-11-15       Impact factor: 7.853

6.  The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice.

Authors:  Bogna M Ignatowska-Jankowska; Pretal P Muldoon; Aron H Lichtman; M Imad Damaj
Journal:  Psychopharmacology (Berl)       Date:  2013-05-08       Impact factor: 4.530

Review 7.  Role of cues and contexts on drug-seeking behaviour.

Authors:  Christina J Perry; Isabel Zbukvic; Jee Hyun Kim; Andrew J Lawrence
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

8.  Effects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and Relapse.

Authors:  Zuzana Justinova; Leigh V Panlilio; Guillermo Moreno-Sanz; Godfrey H Redhi; Alessia Auber; Maria E Secci; Paola Mascia; Tiziano Bandiera; Andrea Armirotti; Rosalia Bertorelli; Svetlana I Chefer; Chanel Barnes; Sevil Yasar; Daniele Piomelli; Steven R Goldberg
Journal:  Neuropsychopharmacology       Date:  2015-03-10       Impact factor: 7.853

9.  Prior exposure to THC increases the addictive effects of nicotine in rats.

Authors:  Leigh V Panlilio; Claudio Zanettini; Chanel Barnes; Marcelo Solinas; Steven R Goldberg
Journal:  Neuropsychopharmacology       Date:  2013-01-11       Impact factor: 7.853

10.  Therapeutic modulation of cannabinoid lipid signaling: metabolic profiling of a novel antinociceptive cannabinoid-2 receptor agonist.

Authors:  Jodianne T Wood; Dustin M Smith; David R Janero; Alexander M Zvonok; Alexandros Makriyannis
Journal:  Life Sci       Date:  2012-06-28       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.